商业与经济
Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
来源: Business News · 发布于
Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.
Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.
相关报道
Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s
As Novo works to turn itself around, some analysts say Lilly has advantages that could help it maintain its position at the top of the obesity drug market.
Business News ·
MGM CEO leaves door open to People Inc. bid as casino dealmaking heats up
The Wall Street Journal reported MGM was exploring an offer for People Inc. after People Inc. withdrew its $48.30-per-share proposal to buy the rest of MGM.
Business News ·
Government must stop dithering over energy bill support for the vulnerable | Nils Pratley
Ministers should introduce a properly targeted social tariff rather than tinker with the warm homes discount Energy bills forecast to jump by £276 a year from January What to do as prices head for £2,000 a year After the hopeful good vibes in Liverpool, here comes a reminder of w
Business | The Guardian ·
Stellantis CEO reconfirms 2026 guidance, says turnaround plan continues as automaker's shares hit new low
Stellantis CEO Antonio Filosa on Wednesday reconfirmed the company's 2026 guidance and its plans to be cash flow positive by 2027.
Business News ·
Energy bills: what to do as prices head for £2,000 a year, from switching deals to insulating
The price cap is to soar for about 20 million households in Great Britain from January, but there are ways to save Energy bills in Great Britain forecast to jump by £276 a year from January Household energy prices are set to soar in January, with a typical bill forecast to jump b
Business | The Guardian ·